Animal model of impaired autoregulation for study of age related vascular cognitive impairment
用于研究年龄相关血管认知障碍的自动调节受损动物模型
基本信息
- 批准号:9197938
- 负责人:
- 金额:$ 22.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-01-01 至 2018-11-30
- 项目状态:已结题
- 来源:
- 关键词:AdultAgeAge of OnsetAgingAlzheimer&aposs DiseaseAnimal GeneticsAnimal ModelAnimalsBackBlood - brain barrier anatomyBlood VesselsBrainCerebral perfusion pressureCerebrovascular CirculationCerebrovascular DisordersCerebrumChromosomes, Human, Pair 1ChronicChronic Kidney FailureCommunitiesDementiaDevelopmentEdemaElderlyExhibitsExtravasationGene FamilyGenesGeneticGenetic Predisposition to DiseaseHomeostasisHuman GenomeHypertensionImpaired cognitionImpairmentIn VitroIncidenceIndividualInjuryKnock-inKnock-outLaboratoriesLearningLinkMediatingMedicalMedicareMemoryMicrocirculationMicrovascular DysfunctionModelingMutationNamesNerve DegenerationNorwayOrganOxygenPatientsPlayPopulationRattusRattus norvegicusRegulationReportingRoleSingle Nucleotide PolymorphismStrokeTestingTransgenic OrganismsTreatment CostUnited StatesVascular Cognitive ImpairmentVascular DementiaVascular DiseasesVascular remodelingadducinage relatedagedbasecerebrovascularcognitive abilitydiabetic patientgamma-adducingenome wide association studyhypertension treatmentin vivoinsightknock-downmiddle cerebral arterynormotensivenovelpressurepreventprotein functionpublic health relevanceresponsetransmission process
项目摘要
DESCRIPTION (provided by applicant): Vascular cognitive impairment (VCI) in elderly is a medical crisis in the United States. VCI is closely associated with hypertension. 67 millions of adults in the United States (33.3% of the population) have hypertension and over 40% of hypertensive patients develop VCI. The Medicare costs for the treatment of hypertension exceeds $47 billion/year and 159 billion/year for dementia. Aged people, especially those with hypertension that is associated with a higher incidence of developing vascular cognitive impairments (VCI) commonly have impaired myogenic response and autoregulation of cerebral blood flow (CBF). However, the mechanism of how these cerebral vascular impairments contribute to the development of VCI is still obscure, part of the reason has been the lack of genetic animal models exhibiting an impaired myogenic response. We first discovered that FHH rats have impaired myogenic response of middle cerebral artery (MCA) and fail to autoregulate in the cerebral circulation, and this impairment is restored by substitution of 2.4 Mbp of chromosome 1 of Brown Norway (BN) rats containing 15 genes including Add3. In the preliminary studies, we found that the expression of Add3 is reduced in FHH relative to FHH.1BN rats and the rescued vascular reactivity of MCA in FHH.1BN rats was back to be impaired after knocking down of Add3 using DsiRNA. We also have preliminary results in the whole animal level to support this view using our newly generated Add3 transgenic and knockout (KO) rat models. As expected, KO of Add3 impairs, and knockin of wildtype (WT) Add3 enhances the myogenic response in freshly isolated MCA in vitro and autoregulation of CBF in vivo. Moreover, we observed vascular remodeling, blood-brain barrier (BBB) leakage, neurodegeneration, learning and memory cognitive impairments those are all characters' of VCI after induction of hypertension in FHH rats. Thus, we hypothesize that Add3 plays an important role in the regulation of impaired myogenic response and autoregulation of CBF, and contributes to the development of age and hypertension related VCI in FHH rats. In this proposal, we will use our newly created Add3 transgenic FHH rats (FHH.Add3TG) vs. FHH rats to examine the myogenic response and autoregulation of CBF, as well as the development of VCI as they age and after the induction of hypertension. These studies should provide novel insights into the role of Add3 in the regulation of the myogenic response and its contribution to age-related small vessel disease, especially in hypertensive individuals, and supply the scientific community with the first genetic animal model in which the myogenic response is impaired to study mechanisms involved in VCI as age. The results will be critical for the development of new treatments to postpone the onset of age and hypertension related vascular diseases.
描述(由申请人提供):老年人血管性认知障碍(VCI)在美国是一种医疗危机。VCI与高血压密切相关。美国有6700万成年人(占人口的33.3%)患有高血压,超过40%的高血压患者发生VCI。治疗高血压的医疗保险费用超过470亿美元/年,治疗痴呆症的费用超过1590亿美元/年。老年人,特别是那些与血管性认知障碍(VCI)发生率较高相关的高血压患者,通常具有受损的肌源性反应和脑血流量(CBF)的自动调节。然而,这些脑血管损伤如何促进VCI发展的机制仍然不清楚,部分原因是缺乏表现出肌源性反应受损的遗传动物模型。我们首次发现FHH大鼠大脑中动脉(MCA)的肌源性反应受损,并且不能在脑循环中进行自动调节,并且通过替换包含Add 3等15个基因的Brown Norway(BN)大鼠1号染色体的2.4 Mbp来恢复这种损伤。在初步研究中,我们发现相对于FHH. 1BN大鼠,FHH. 1BN大鼠中Add 3的表达减少,并且在使用DsiRNA敲低Add 3后,FHH. 1BN大鼠中MCA的挽救的血管反应性恢复受损。我们也有初步的结果,在整个动物水平,以支持这一观点,使用我们新产生的Add 3转基因和敲除(KO)大鼠模型。正如预期的那样,KO的Add 3损害,和敲入野生型(WT)的Add 3增强肌原性反应,在新鲜分离的MCA在体外和CBF在体内的自动调节。此外,我们还观察到FHH大鼠高血压后血管重构、血脑屏障(blood-brain barrier,BBB)渗漏、神经退行性变、学习记忆和认知功能障碍等均为VCI的特征。因此,我们推测,Add 3在调节受损的生肌反应和CBF的自动调节中起着重要作用,并有助于FHH大鼠中年龄和高血压相关VCI的发展。在这项提议中,我们将使用我们新创建的Add 3转基因FHH大鼠(FHH.Add3TG)与FHH大鼠来检查CBF的生肌反应和自动调节,以及随着年龄的增长和诱导高血压后VCI的发展。这些研究应提供新的见解Add 3在调节肌源性反应的作用及其对年龄相关性小血管疾病的贡献,特别是在高血压个体中,并为科学界提供第一个遗传动物模型,其中肌源性反应受损,以研究年龄相关的VCI机制。这些结果对于开发新的治疗方法以推迟年龄和高血压相关血管疾病的发病至关重要。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Current Opinion in Nephrology and Hypertension. Current world literature.
肾脏病学和高血压的当前观点。
- DOI:10.1097/mnh.0b013e3283372e11
- 发表时间:2010
- 期刊:
- 影响因子:3.2
- 作者:
- 通讯作者:
Diffusion-weighted 7.0T Magnetic Resonance Imaging in Assessment of Intervertebral Disc Degeneration in Rats.
- DOI:10.4103/0366-6999.221261
- 发表时间:2018-01-05
- 期刊:
- 影响因子:6.1
- 作者:Li LY;Wu XL;Roman RJ;Fan F;Qiu CS;Chen BH
- 通讯作者:Chen BH
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Fan Fan其他文献
Fan Fan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Fan Fan', 18)}}的其他基金
Vascular mechanisms of inhibition of sEH as a novel therapy for AD/ADRD
抑制 sEH 作为 AD/ADRD 新疗法的血管机制
- 批准号:
10525694 - 财政年份:2022
- 资助金额:
$ 22.88万 - 项目类别:
Adducin, actin cytoskeleton and cognitive impairments
内收蛋白、肌动蛋白细胞骨架和认知障碍
- 批准号:
9897521 - 财政年份:2019
- 资助金额:
$ 22.88万 - 项目类别:
Adducin, actin cytoskeleton and cognitive impairments
内收蛋白、肌动蛋白细胞骨架和认知障碍
- 批准号:
10343669 - 财政年份:2019
- 资助金额:
$ 22.88万 - 项目类别:
Adducin, actin cytoskeleton and cognitive impairments
内收蛋白、肌动蛋白细胞骨架和认知障碍
- 批准号:
10092053 - 财政年份:2019
- 资助金额:
$ 22.88万 - 项目类别:
相似国自然基金
巨噬细胞CD38通过调节肾小管NAD+水平影响年龄相关急性肾损伤易感性的机制研究
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
血视网膜屏障抗菌肽的表达及与AMD的相关性研究
- 批准号:2025JJ90270
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
高压氧条件下年龄相关脑淋巴功能变化的机制研究
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
时空随机业务场景下面向同步年龄的大规模接入技术研究
- 批准号:QN25F010050
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于内皮细胞铁死亡探讨SDF-1/CXCR7轴在年龄相关性黄斑变性中的作用及机制研究
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
眼病精准诊疗技术与创新药物、装备研发及应用-基于疾病风险预警系统和新药研发的年龄相关性白内障早期精准诊疗新策略
- 批准号:2025C02157
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
TET2通过调控Fabp4+巨噬细胞代谢重编程参与新生血管性年龄相关性黄斑变性的机制研究
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
仿生纳米颗粒介导CNV周围NO梯度的构建及其调控AMD血管正常化的研究
- 批准号:QN25H120008
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
相似海外基金
Determining the mechanism of action of cis-acting modifiers on the age of onset of Huntington Disease
确定顺式作用修饰剂对亨廷顿病发病年龄的作用机制
- 批准号:
417256 - 财政年份:2019
- 资助金额:
$ 22.88万 - 项目类别:
Studentship Programs
Effect of age of onset of contraception use on brain functioning.
避孕开始年龄对大脑功能的影响。
- 批准号:
511267-2017 - 财政年份:2017
- 资助金额:
$ 22.88万 - 项目类别:
University Undergraduate Student Research Awards
Non-random occurrence and early age of onset of diverse lymphoid cancers in families supports the existence of genetic risk factors for multiple lymphoid cancers.
家族中多种淋巴癌的非随机发生和发病年龄较早,支持多种淋巴癌存在遗传危险因素。
- 批准号:
347105 - 财政年份:2016
- 资助金额:
$ 22.88万 - 项目类别:
Polish-German Child Bilingualism: The Role of Age of Onset for Long-Term Achievement
波兰-德国儿童双语:发病年龄对长期成就的作用
- 批准号:
277135691 - 财政年份:2015
- 资助金额:
$ 22.88万 - 项目类别:
Research Grants
Bioinformatics strategies to relate age of onset with gene-gene interaction
将发病年龄与基因间相互作用联系起来的生物信息学策略
- 批准号:
9097781 - 财政年份:2015
- 资助金额:
$ 22.88万 - 项目类别:
Early Age-of-Onset AD: Clinical Heterogeneity and Network Degeneration
早期 AD 发病年龄:临床异质性和网络退化
- 批准号:
9212684 - 财政年份:2014
- 资助金额:
$ 22.88万 - 项目类别:
Early Age-of-Onset AD: Clinical Heterogeneity and Network Degeneration
早期 AD 发病年龄:临床异质性和网络退化
- 批准号:
8696557 - 财政年份:2014
- 资助金额:
$ 22.88万 - 项目类别:
Effects of delaying age of onset of binge drinking on adolescent brain development: A proposal to add neuroimaing measures to the CO-Venture Trial.
延迟酗酒的发病年龄对青少年大脑发育的影响:在 CO-Venture 试验中添加神经影像测量的建议。
- 批准号:
267251 - 财政年份:2012
- 资助金额:
$ 22.88万 - 项目类别:
Operating Grants
Stress Effects on Alcohol Consumption: Age of onset and genes in heavy drinkers
压力对饮酒的影响:酗酒者的发病年龄和基因
- 批准号:
8606722 - 财政年份:2012
- 资助金额:
$ 22.88万 - 项目类别:
Marijuana: Neurobiologic Correlates of Age of Onset
大麻:发病年龄的神经生物学相关性
- 批准号:
8644793 - 财政年份:2012
- 资助金额:
$ 22.88万 - 项目类别: